Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

Journal of the American College of Cardiology

Volumn 27, Issue 5, 1996, Pages 1201-1206

  Torre Amione, Guillermo ^a   Kapadia, Samir ^a   Benedict, Claude ^b   Oral, Hakan ^a   Young, James B ^a   Mann, Douglas L ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYTOKINE; INTERLEUKIN 6; NEUROHORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL;

EID: 0029871896     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00589-7     Document Type: Article

References (25)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;223:236-41.
2. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
3. Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil Superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 1993;22:1897-901.
4. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumour necrosis factor-alpha in severe congestive cardiac failure. Br Heart J 1993;70:141-3.
5. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994;90:12-6.
6. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-6.
7. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321: 280-7.
8. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet 1990;2:294-5.
9. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GA. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989;2:712-3.
10. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994;105:897-904.
11. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995;92:1379-82.
12. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;327:685-91.
13. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
14. Benedict CR, Johnstone DE, Weiner DH, et al. Relation of neurohormonal activation to clinical variables and degree of ventricular dysfunction: a report from the registry of studies of left ventricular dysfunction. J Am Coll Cardiol 1994;23:1410-20.
15. Riches P, Gooding R, Millar BC, Rowbottom AW. Influence of collection and separation of blood samples on plasma IL-I, IL-6 and TNF-α concentrations. J Immunol Methods 1992;153:125-31.
16. Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA. Measuring circulating cytokines. J Appl Physiol 1993;75:1897-902.
17. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. J Immunol Methods 1992;153:115-24.
18. Kapadia S, Torre-Amione G, Mann DL. Comments on "Plasma cytokine and endotoxin levels in patients with sepsis syndrome" which appeared in Annals of Internal Medicine 1993;119:771-854. Ann Intern Med 1994;121: 149.
19. Kapadia S, Torre-Amione G, Mann DL. Comments on "Plasma cytokine and endotoxin levels in patients with sepsis syndrome" which appeared in Annals of Internal Medicine 1993;119:771-854. Ann Intern Med 1994;121: 149.
20. Johnstone D, Limacher M, Rousseau M, et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol 1992;70:894-900.
21. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
22. Gottleib SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534-9.
23. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. In press.
24. Gilbert EM, Munger MA, Johnson B, Amber IJ, Stoddard GJ. Augmented lymphokine production in moderate heart failure population [abstract]. J Am Coll Cardiol 1993;21:268A.
25. Tsutamoto T, Hisanaga T, Wada A, Maeda Y, Fukai D. Plasma concentration of interleukin-6 as a marker of prognosis in patients with chronic congestive heart failure [abstract]. Circulation 1994;90 Suppl I:I-381.